A third dose of Pfizer/BioNTech’s COVID-19 vaccine is authorized for kids ages 5 to 11 years, the FDA announced on Tuesday. The third 10 μg dose may be administered to children at least 5 months after the initial primary series under the terms of the emergency use authorization (EUA), the agency […]
Read More
Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to allow for use of a single booster dose, to be administered at least six months after completion of the primary series in: individuals 65 years of age and older; individuals 18 […]
Read More
The CDC is expected to sign off on the move Wednesday, making Thursday the first day shots could be available for children 12 to 15 years old. By Erika Edwards. The Food and Drug Administration on Monday lowered the age that people can receive Pfizer’s Covid-19 vaccine in the United States […]
Read More